The Frontier Psychiatrists

The Frontier Psychiatrists

Share this post

The Frontier Psychiatrists
The Frontier Psychiatrists
Gabapentin

Gabapentin

The drug that didn't do much off-label

Owen Scott Muir, M.D, DFAACAP's avatar
Owen Scott Muir, M.D, DFAACAP
Nov 08, 2023
∙ Paid
7

Share this post

The Frontier Psychiatrists
The Frontier Psychiatrists
Gabapentin
20
2
Share

The Frontier Psychiatrists is a newsletter. It’s also now a podcast. It is also now a live event production workshop, also! We have our first live event on the Sunday night before JPM Healthcare 2024. It’s called Rapid Acting Mental Health Treatment 2024, and you should get your ticket now!

But today, we bring you another installment in our exploration of the small molecule oral medicines of yesterday….

As a brief plug, I work at Fermata, and I don’t do small molecule pharmacology first line any more. I still see patients, who live in states in which I’m licensed and for research by the way!

Gabapentin is a misleading name for a drug—it has no activity at GABA receptors. The brand name is Neurontin, now a part of the Pfizer family of pharmaceuticals.

“It is of paramount importance that the Department use every legal tool at its disposal…to pursue companies and individuals…that inflict suffering on patients and families”

—US Attorney Michael Sullivan, Regarding Marketing of Gabape…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 The Frontier Psychiatrists
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share